Latest stories

  • in

    SII in talks on fill finishing Oxford University R21 malaria vaccine in Ghana: Expert

    Bengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University‘s R21 malaria vaccine in Ghana, which approved the shot this month, a Ghanaian vaccine expert said on Thursday. Fill-finishing is one of the final stages of drug manufacturing and packaging. The vaccine’s approval by Ghana and Nigeria was unusual because final-stage […] More

  • in

    CCI approves acquisition of up to 76.10 percent of voting share capital of Suven Pharma by Berhyanda

    New Delhi: Anti-trust regulator Competition Commission of India (CCI) approves the acquisition of up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited. The proposed combination relates to acquisition by Berhyanda Limited (Acquirer) for up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited (Target), by way of a […] More

  • in

    PGI Chandigarh gets alcohol use disorder clinic for liver ailments

    Chandigarh: With an aim to prevent alcohol-induced liver diseases, the Post Graduate Institute of Medical Education and Research (PGI Chandigarh) has launched an alcohol use disorder (AUD) clinic on World Liver Day, observed on April 19 every year through a collaboration between the Department of Hepatology and the Department of Psychiatry within the institute. The […] More

  • in

    Around 80000 Candidates Registered For NEET UG 2023 from Gujarat

    Gujarat: In the state of Gujarat, NEET UG 2023 will be conducted on 7 May 2023 in both English and Gujarati languages. Around 80000 candidates across Gujarat have registered for the exam, according to TOI report. Last year around 79000 candidates registered for the NEET UG exam in the state. This year not much increase in […] More

  • in

    Combination therapy with oral fluvoxamine and inhaled budesonide significantly Cuts Severe Disease in COVID-19

    Researchers have found in a randomized controlled trial that treatment with oral antidepressant fluvoxamine plus inhaled budesonide among high-risk outpatients with early COVID-19 reduced the incidence of severe disease requiring advanced care. Previous studies evaluated these drugs independently. The combined effect seems to offer benefits over individual use of each drug. The findings are published […] More

  • in

    Women Kept Out Of Clinical Trials For Long: What Are The Dangers Of It?

    In recent times, we have started to understand that many women might go undiagnosed for a cardiac event like a heart attack because they don’t fit the stereotypical symptoms such as the classic pain in the chest. They might instead experience extreme fatigue or a feeling of having bad acid reflux. If men and women […] More

  • in

    El Nino Predicted This Year: Will India Witness Deadly Heat Waves?

    With already soaring mercury in the country, it might not be good news for India as many parts of the world including it prepare for El Nino, a climate pattern predicted this year and which is associated with severe heat waves and droughts. El Nino is a climate pattern that describes the unusual warming of […] More

  • in

    Uncovering a Predictive Biomarker for Alzheimer’s

    Researchers publishing in Alzheimer’s and Dementia have published a correlation between the Alzheimer’s-linked protein tau and another protein, bisecting N-acetylglucosamine (GlcNAc), which suggests its usefulness as a biomarker. The need for early prediction This paper begins with a note that to be effective, Alzheimer’s treatment must begin before irrevocable neurodegeneration has already occurred [1]. Therefore, […] More

Load More
Congratulations. You've reached the end of the internet.